GE Healthcare Unveils MIM KineticID Software to Advance Dynamic PET Analysis
Advertisement
It offers a comprehensive suite of workflows for kinetic modeling and parametric imaging, with intuitive 4D visualization, Patlak analysis (both absolute and relative), and customizable curve fitting capabilities.
GE HealthCare has introduced its MIM KineticID, a modeling software aimed at strengthening access to advanced quantitative imaging and dynamic PET analysis.
The software is intended to support dynamic PET workflows and kinetic modeling, enabling clinicians and researchers to better understand how radiotracers move through the body over time.
By providing a more comprehensive view of tracer behavior, the platform aims to enhance disease assessment and support more informed clinical and research decisions.
Conventionally, PET imaging largely relies on visual interpretation of static images and simplified metrics like the standardized uptake value
such as standardized uptake value (SUV), which captures only a single point in time, making it more difficult for clinicians to accurately quantify tracer uptake and distinguish between malignant and inflammatory lesions.
As per the company, the 4D dynamic PET aims to address these limitations by continuously tracking tracer distribution in both tissue and blood.
This approach is expected to enable more accurate quantification of biological processes and improved differentiation between malignant and inflammatory lesions.
MIM KineticID is designed to make advanced dynamic imaging more practical and accessible for clinicians and researchers.
It offers a comprehensive suite of workflows for kinetic modeling and parametric imaging, with intuitive 4D visualization, Patlak analysis (both absolute and relative), and customizable curve fitting capabilities.
The platform is designed to deliver precise and reproducible measurements of biological activity, including tracer uptake rates and metabolic processes.
In addition, the solution also supports rapid whole-body dynamic analysis with automated labeling, flexible modeling tools for plasma and tissue tracer concentration, and side-by-side comparison of multiple tracers such as FDG and PSMA.
These capabilities are intended to enable clinicians to visualize, summarize, and export findings for improved collaboration and clinical decision-making.
Further, as part of the vendor-neutral MIM software ecosystem, the platform supports DICOM data from any PET system and integrates multi-modality fusion, therapy response assessment, and advanced imaging analysis.
The latest platform is expected to support healthcare providers and researchers in maximizing the value of imaging data while advancing future innovations in precision medicine and molecular imaging.
Reportedly, the approval for the MIM KineticID modeling software is now pending with the U.S. Food and Drug Administration (FDA).
Stay tuned for more such updates on Digital Health News
